PKO Investment Management Joint-Stock’s Bristol-Myers Squibb BMY Stock Holding History

PKO Investment Management Joint-Stock’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.21M	Sell	21,000 -2,000	-9%	-$115K	0.09%	158
2026 Q1	$1.39M	Sell	23,000 -3,000	-12%	-$175K	0.12%	137
2025 Q4	$1.4M	Sell	26,000 -2,500	-9%	-$120K	0.11%	143
2025 Q3	$1.29M	Hold	28,500	–	–	0.11%	133
2025 Q2	$1.32M	Buy	28,500 +16,500	+138%	+$810K	0.14%	113
2025 Q1	$732K	Sell	12,000 -4,000	-25%	-$233K	0.08%	145
2024 Q4	$905K	Sell	16,000 -4,000	-20%	-$223K	0.11%	111
2024 Q3	$1.03M	Hold	20,000	–	–	0.13%	104
2024 Q2	$831K	Hold	20,000	–	–	0.1%	123
2024 Q1	$1.09M	Sell	20,000 -14,000	-41%	-$713K	0.13%	116
2023 Q4	$1.74M	Hold	34,000	–	–	0.22%	77
2023 Q3	$1.97M	Hold	34,000	–	–	0.27%	61
2023 Q2	$2.17M	Buy	34,000 +11,000	+48%	+$738K	0.27%	66
2023 Q1	$1.59M	Hold	23,000	–	–	0.21%	87
2022 Q4	$1.65M	Buy	23,000 +1,000	+5%	+$75.4K	0.24%	76
2022 Q3	$1.56M	Sell	22,000 -2,000	-8%	-$145K	0.27%	70
2022 Q2	$1.85M	Sell	24,000 -1,000	-4%	-$76.2K	0.27%	74
2022 Q1	$1.83M	Sell	25,000 -30,000	-55%	-$2.01M	0.22%	79
2021 Q4	$3.43M	Buy	55,000 +25,599	+87%	+$1.5M	0.39%	59
2021 Q3	$1.74M	Hold	29,401	–	–	0.21%	81
2021 Q2	$1.96M	Hold	29,401	–	–	0.25%	65
2021 Q1	$1.86M	Hold	29,401	–	–	0.3%	52
2020 Q4	$1.82M	Hold	29,401	–	–	0.31%	51
2020 Q3	$1.77M	Hold	29,401	–	–	0.34%	53
2020 Q2	$1.73M	Hold	29,401	–	–	0.39%	50
2020 Q1	$1.64M	Hold	29,401	–	–	0.56%	42
2019 Q4	$1.89M	Buy	29,401 +11,157	+61%	+$639K	0.47%	50
2019 Q3	$925K	Hold	18,244	–	–	0.23%	66
2019 Q2	$827K	Hold	18,244	–	–	0.21%	68
2019 Q1	$870K	Hold	18,244	–	–	0.23%	70
2018 Q4	$948K	Hold	18,244	–	–	0.27%	62
2018 Q3	$1.13M	Hold	18,244	–	–	0.23%	58
2018 Q2	$1.01M	Sell	18,244 -5,697	-24%	-$308K	0.21%	65
2018 Q1	$1.51M	Hold	23,941	–	–	0.34%	50
2017 Q4	$1.47M	Buy	23,941 +2,944	+14%	+$184K	0.37%	52
2017 Q3	$1.34M	Buy	20,997 +7,867	+60%	+$459K	0.36%	50
2017 Q2	$732K	Buy	13,130 +7,651	+140%	+$416K	0.25%	54
2017 Q1	$298K	Buy	+5,479	New	+$301K	0.14%	62

Other funds holding BMY

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

MGP

M&G plc London, United Kingdom $20.1B AUM 16.62% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

KBC Group Brussels, Belgium $46.3B AUM 43.9% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

PKO Investment Management Joint-Stock's BMY Position: Q2 2026 in Review

PKO Investment Management Joint-Stock reduced its Bristol-Myers Squibb (BMY) stake by 8.7% in Q2 2026, selling an estimated $115K and leaving 21,000 shares worth $1.21M. The position accounts for 0.09% of the portfolio, ranked #158.

PKO Investment Management Joint-Stock first reported a position in BMY in Q1 2017 and has held it in 38 quarters since. The position peaked at $3.43M in Q4 2021. 1,475 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

PKO Investment Management Joint-Stock held 21,000 shares of Bristol-Myers Squibb worth $1.21M as of Q2 2026.
PKO Investment Management Joint-Stock sold 2,000 Bristol-Myers Squibb shares in Q2 2026, an estimated $115K.
Bristol-Myers Squibb made up 0.09% of PKO Investment Management Joint-Stock's portfolio in Q2 2026, its #158 holding.
PKO Investment Management Joint-Stock first reported a position in Bristol-Myers Squibb in Q1 2017 and has held it in 38 quarters since.
PKO Investment Management Joint-Stock's Bristol-Myers Squibb position peaked at $3.43M in Q4 2021.
1,475 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on PKO Investment Management Joint-Stock's 13F filing for Q2 2026, filed 20 Jul 2026.